Nine Masts Capital »

Apogee Therapeutics shares owned by Nine Masts Capital

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Nine Masts Capital from 13F filings

Historical chart of Nine Masts Capital investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Nine Masts Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Nine Masts Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.2M 9.4k 132.73

More positions owned by Nine Masts Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Hdfc Bank Sponsored Ads (HDB)
Warner Bros Discovery Com Ser A (WBD)
Fox Corp Cl B Com (FOX)
Silicon Laboratories (SLAB)
Kenvue (KVUE)
Electronic Arts (EA)
Palo Alto Networks Call Option (PANW)
Nio Note 4.625%10/1 (Principal)
Super Micro Computer Note 3.500% 3/0 (Principal)
Norfolk Southern (NSC)
Akamai Technologies Note 0.250% 5/1 (Principal)
Barclays Adr (BCS)
Qorvo (QRVO)

View all positions for Nine Masts Capital

Top funds holding Apogee Therapeutics

VR Adviser
BlackRock
HBK Investments
Vanguard Capital Management
FMR
Henderson Group
Balyasny Asset Management
State Street Corporation
Driehaus Capital Management
Goldman Sachs Group
Glazer Capital
Paradigm Biocapital Advisors
Vanguard Portfolio Management
Millennium Management
Pentwater Capital Management

View all funds holding Apogee Therapeutics